Aggressive non-Hodgkin lymphoma
Clinical trials for Aggressive non-Hodgkin lymphoma explained in plain language.
Never miss a new study
Get alerted when new Aggressive non-Hodgkin lymphoma trials appear
Sign up with your email to follow new studies for Aggressive non-Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on hard-to-treat lymphoma shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two antibody drugs (mosunetuzumab and polatuzumab) after standard CAR-T cell therapy can improve tumor shrinkage in people with aggressive non-Hodgkin lymphoma that has relapsed or not responded to prior treatments. About 22 adults will receive the…
Matched conditions: AGGRESSIVE NON-HODGKIN LYMPHOMA
Phase 2 • Sponsor: Lazaros Lekakis • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Smart scales could help keep blood cancer patients safe at home
Knowledge-focused Recruiting nowThis study looks at whether a connected scale can help monitor blood cancer patients (with lymphoma or myeloma) during chemotherapy. Thirty patients will weigh themselves daily for about 7 weeks, and their data will be sent to their medical team. The goal is to see if this approa…
Matched conditions: AGGRESSIVE NON-HODGKIN LYMPHOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:01 UTC